- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05965544
The Effect of Fascia Iliaca Compartment Block (FICB) on QoR-15 Score in Partial Hip Arthroplasty Surgery (QoR-15)
May 14, 2024 updated by: Ergün Mendeş, Başakşehir Çam & Sakura City Hospital
The Effect of Application of Fascia Iliaca Compartment Block (FICB) Before or After Spinal Anesthesia on QoR-15 Score in Partial Hip Arthroplasty Surgery
It reduces pain scores in patients with block and improves the quality of recovery in the postoperative period.
In patients who will undergo spinal anesthesia, it will be questioned whether the application of the block before or after surgery makes a difference in the quality of recovery.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
American Society of Anesthesiologists (ASA) physical status I-III patients who are planned for partial hip arthroplasty will be studied in patients over 65 years of age.
The patients will be equally randomized into two groups using a computer-generated random number table.
In the preoperative period, according to whether FIBP was before or after spinal anesthesia, it will be named as a separate group as Group PreS (Pre-Spinal) and Group PostS (Post-Spinal).
The patient will be placed in the lateral decubitus position with the fractured side up.
After the spinal anesthesia method was provided with aseptic conditions, 10 mg 0.5% isobaric bupivacaine + 20 mcg Fentanyl injection will be applied using a 26 Gauge pencil point needle through the L3-L4 or L4-L5 intervertebral space.
After the patients are in the supine position and aseptic conditions are provided, the fascia on the Iliacus muscle will be determined with the help of an 8-12 MHz linear probe, and the block will be applied with the in-plane technique.
During the block, patients will routinely administer 0.2% bupivacaine concentration of 0.5 mL/kg.
Demographic data, operation time, perioperative analgesic and sedation need, postoperative pain scores, additional analgesic need, hospitalization and 24th-hour recovery scores will be evaluated.
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
İ̇stanbul
-
Küçükçekmece, İ̇stanbul, Turkey, 34000
- Ergun Mendes
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Partial Hip Arthroplasty
- American Society of Anesthesiologists (ASA) physical status I-III,
- Patients aged ≥ 65 years
Exclusion criteria:
- Contraindication for central or peripheral blocks,
- Cognitive Dysfunction,
- History of chronic opioid use,
- Previous hip surgery,
- Serious organ dysfunction,
- Allergy to any drug used in the study,
- Body mass index (BMI) ≥30,
- Infection in the area to be treated,
- Refusal to participate in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Group PreS
The block will be applied in the preoperative period
|
After the patients are in the supine position and aseptic conditions are provided in the preoperative period, the fascia on the iliacus muscle will be determined with the help of an 8-12 MHz linear probe and a block will be applied with the in-plane technique.
During the block, 0.2% bupivacaine concentration 0.5 mL/kg is routinely used in patients.
Other Names:
The patient will be placed in the lateral decubitus position with the fractured side up.
After the spinal anesthesia method was provided with aseptic conditions, 10 mg 0.5% bupivacaine + 20 mcg Fentanyl injection will be applied using a 26 Gauge pencil point needle through the L3-L4 or L4-L5 intervertebral space
Other Names:
|
|
Active Comparator: Group PostS
The block will be applied in the postoperative period
|
The patient will be placed in the lateral decubitus position with the fractured side up.
After the spinal anesthesia method was provided with aseptic conditions, 10 mg 0.5% bupivacaine + 20 mcg Fentanyl injection will be applied using a 26 Gauge pencil point needle through the L3-L4 or L4-L5 intervertebral space
Other Names:
After the patients are in the supine position and aseptic conditions are provided in the postoperative period, the fascia on the iliacus muscle will be determined with the help of an 8-12 MHz linear probe and a block will be applied with the in-plane technique.
During the block, 0.2% bupivacaine concentration 0.5 mL/kg is routinely used in patients.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline QoR-15 at 24 hours postoperatively
Time Frame: Postoperative 24th-hours
|
The patient-reported Turkish QoR-15 score includes 15 questions that evaluate the patient's postoperative recovery.
The QoR-15 score is grouped under two groups, A and B. A high QoR-15 score, a score between 0 (poor) and 10 (excellent) for each item, and a total score of 150 indicate better quality of recovery.
|
Postoperative 24th-hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative nausea and vomiting
Time Frame: Postoperative 24th hour
|
The frequency of nausea and vomiting in the postoperative period was calculated according to the Numeric Rank Score (NRS), which ranged from 0 to 3. Nausea-vomiting status of the patients: 0 points if there is no nausea and vomiting; 1 point if there is nausea, no vomiting; It is scored as 2 points if there is vomiting once and 3 points if there are two or more vomiting attacks.
|
Postoperative 24th hour
|
|
Change from baseline Nursing Delirium Screening Scale (N-DSS) at 24 hours postoperatively
Time Frame: Postoperative 24th-hours
|
Postoperative delirium will be determined with the Nursing Delirium Screening Scale (N-DSS), an easily applicable five-item screening tool that evaluates disorientation, inappropriate behavior, inappropriate communication, hallucination, and psychomotor retardation.
Each item scores between 0 and 2 and the total score varies between 0 and 10.
|
Postoperative 24th-hours
|
|
Analgesic consumption
Time Frame: Postoperative 24th hour
|
The value in mg of the amount of analgesic consumed in the postoperative period
|
Postoperative 24th hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Ergun Mendes, Başakşehir Çam & Sakura City Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 2, 2023
Primary Completion (Actual)
May 14, 2024
Study Completion (Actual)
May 14, 2024
Study Registration Dates
First Submitted
July 13, 2023
First Submitted That Met QC Criteria
July 20, 2023
First Posted (Actual)
July 28, 2023
Study Record Updates
Last Update Posted (Actual)
May 16, 2024
Last Update Submitted That Met QC Criteria
May 14, 2024
Last Verified
May 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Postoperative Complications
- Pain
- Neurologic Manifestations
- Fractures, Bone
- Wounds and Injuries
- Leg Injuries
- Femoral Fractures
- Hip Injuries
- Pain, Postoperative
- Hip Fractures
- Physiological Effects of Drugs
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Anesthetics, Intravenous
- Anesthetics, General
- Anesthetics
- Analgesics, Opioid
- Narcotics
- Adjuvants, Anesthesia
- Anesthetics, Local
- Fentanyl
- Bupivacaine
Other Study ID Numbers
- e.mendes - 2
- KAEK/2023.06.259 (Other Identifier: Basaksehir Cam and Sakura City Hospital)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Individual participant data (IPD) will not be shared
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anesthesia, Local
-
University Health Network, TorontoActive, not recruiting
-
Assistance Publique - Hôpitaux de ParisINSERM UMR-942, Paris, France; M3DISIMRecruitingPrediction Models for Cardiovascular and Neurocognitive Disease Risk in the General Population (CME)Anesthesia, Local | AnesthesiaFrance
-
Charite University, Berlin, GermanyCompletedAnesthesia, Local | AnesthesiaGermany
-
Grünenthal GmbHTerminatedAnalgesia | Anesthesia, Local | AnesthesiaNetherlands
-
Charite University, Berlin, GermanyCompletedAnesthesia, Local | Anesthesia | Anesthesia; Adverse EffectGermany
-
Assistance Publique - Hôpitaux de ParisINSERM UMR-942, Paris, France; M3DISIMRecruiting
-
Novocol Pharmaceutical of Canada, Inc.CompletedAnesthesia, Local | Dental Anesthesia | Anesthesia, ReversalUnited States
-
Kfir SiagNot yet recruiting
-
University Health Network, TorontoCompleted
-
Hams Hamed AbdelrahmanCompleted
Clinical Trials on Bupivacain (preoperative)
-
Benha UniversityCompletedPain Management | Cervical Spine SurgeryEgypt
-
Federal University of Mato GrossoCompleted
-
Uppsala University HospitalRegion Stockholm; Capio Research FoundationCompleted
-
Beni-Suef UniversityCompletedAnterior Cruciate Ligament Injury | Knee JointEgypt
-
Centre Jean PerrinCompleted
-
University of Texas Southwestern Medical CenterUniversity of Texas, Southwestern Medical Center at DallasCompletedPelvic Organ Prolapse | Patient SatisfactionUnited States
-
University of AarhusAarhus University Hospital; Danish Cancer Society; University of Southern DenmarkCompletedHealth and Coping Undergoing Ovarian Cancer Surgery. | Cancer RehabilitationDenmark
-
Indonesia UniversityNot yet recruitingPrehabilitation | Postoperative Inflammation | Locally Advanced Breast Cancer (LABC)Indonesia
-
University of ValenciaHospital Politècnic i Universitari la Fe de ValènciaCompletedKnee OsteoarthritisSpain
-
University of Colorado, DenverCompleted